Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nat Clin Pract Oncol. 2006 Jan; 3(1):50-7; quiz 1 p following 57.